High Expression of Cry1Ac Protein in Cotton (Gossypium hirsutum) by Combining Independent Transgenic Events that Target the Protein to Cytoplasm and Plastids
- PMID: 27391960
- PMCID: PMC4938423
- DOI: 10.1371/journal.pone.0158603
High Expression of Cry1Ac Protein in Cotton (Gossypium hirsutum) by Combining Independent Transgenic Events that Target the Protein to Cytoplasm and Plastids
Abstract
Transgenic cotton was developed using two constructs containing a truncated and codon-modified cry1Ac gene (1,848 bp), which was originally characterized from Bacillus thuringiensis subspecies kurstaki strain HD73 that encodes a toxin highly effective against many lepidopteran pests. In Construct I, the cry1Ac gene was cloned under FMVde, a strong constitutively expressing promoter, to express the encoded protein in the cytoplasm. In Construct II, the encoded protein was directed to the plastids using a transit peptide taken from the cotton rbcSIb gene. Genetic transformation experiments with Construct I resulted in a single copy insertion event in which the Cry1Ac protein expression level was 2-2.5 times greater than in the Bacillus thuringiensis cotton event Mon 531, which is currently used in varieties and hybrids grown extensively in India and elsewhere. Another high expression event was selected from transgenics developed with Construct II. The Cry protein expression resulting from this event was observed only in the green plant parts. No transgenic protein expression was observed in the non-green parts, including roots, seeds and non-green floral tissues. Thus, leucoplasts may lack the mechanism to allow entry of a protein tagged with the transit peptide from a protein that is only synthesized in tissues containing mature plastids. Combining the two events through sexual crossing led to near additive levels of the toxin at 4-5 times the level currently used in the field. The two high expression events and their combination will allow for effective resistance management against lepidopteran insect pests, particularly Helicoverpa armigera, using a high dosage strategy.
Conflict of interest statement
Figures
References
-
- James C. Global Status of Commercialized Biotech/GM Crops: 2014 ISAAA Brief. 2014; 49 (ISAAA: Ithaca, NY.).
-
- Perlak FJ, Oppenhuizen M, Gustafson K, Voth R, Sivasupramaniam S, Heering D, et al. Development and commercial use of Bollgard® cotton in the USA—early promises versus today's reality. Plant J. 2001; 27(6): 489–501. - PubMed
-
- Choudhary B, Gaur K. Biotech Cotton in India, 2002 to 2014 ISAAA Series of Biotech Crop Profiles. 2015; ISAAA: Ithaca, NY.
-
- Edge JM, Benedict JH, Carroll JP, Reding H K. Bollgard cotton: An assessment of global economic, environmental and social benefits. J Cotton Sci. 2001; 5(2): 121–136.
-
- Romeis J, Meissle M, Bigler F. Transgenic crops expressing Bacillus thuringiensis toxins and biological control. Nat Biotechnol. 2006; 24(1): 63–71. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
